Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach

Abstract Septal reduction therapy is the gold standard treatment method for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of transcoronary alcohol septal ablation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of the medical sciences 2016-11, Vol.352 (5), p.466-471
Hauptverfasser: Aksu, Tolga, MD, FESC, Guler, Tumer, MD, Yalin, Kivanc, MD, Golcuk, Sukriye Ebru, MD, Ozcan, Kazim, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Septal reduction therapy is the gold standard treatment method for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of transcoronary alcohol septal ablation has increased precipitously due to less invasive nature of the procedure. Whereas, endocardial septal ablation therapy is a relatively new defined modality and outcomes of the procedure are not clearly elucidated yet. In this review article, we aimed to present non-surgical septal reduction approaches in the patients with HOCM.
ISSN:0002-9629
1538-2990
DOI:10.1016/j.amjms.2016.08.025